Contrast sensitivity evaluation in high risk proliferative diabetic retinopathy treated with panretinal photocoagulation associated or not with intravitreal bevacizumab injections: a randomised clinical trial (2013)
- Authors:
- USP affiliated authors: MONTEIRO, MARIO LUIZ RIBEIRO - FM ; TAKAHASHI, WALTER YUKIHIKO - FM
- Unidade: FM
- DOI: 10.1136/bjophthalmol-2012-302675
- Subjects: TRIAGEM; DIABETES MELLITUS; SENSIBILIDADE E ESPECIFICIDADE; CONTRASTE; FATORES DE RISCO
- Language: Inglês
- Imprenta:
- Source:
- Título: British Journal of Ophthalmology
- ISSN: 0007-1161
- Volume/Número/Paginação/Ano: v. 97, n. 7, p. 885-889, 2013
- Este artigo NÃO possui versão em acesso aberto
-
Status: Nenhuma versão em acesso aberto identificada -
ABNT
PRETI, Rony Carlos et al. Contrast sensitivity evaluation in high risk proliferative diabetic retinopathy treated with panretinal photocoagulation associated or not with intravitreal bevacizumab injections: a randomised clinical trial. British Journal of Ophthalmology, v. 97, n. 7, p. 885-889, 2013Tradução . . Disponível em: https://doi.org/10.1136/bjophthalmol-2012-302675. Acesso em: 12 mar. 2026. -
APA
Preti, R. C., Ramirez, L. M. V., Monteiro, M. L. R., Carra, M. K., Pelayes, D. E., & Takahashi, W. Y. (2013). Contrast sensitivity evaluation in high risk proliferative diabetic retinopathy treated with panretinal photocoagulation associated or not with intravitreal bevacizumab injections: a randomised clinical trial. British Journal of Ophthalmology, 97( 7), 885-889. doi:10.1136/bjophthalmol-2012-302675 -
NLM
Preti RC, Ramirez LMV, Monteiro MLR, Carra MK, Pelayes DE, Takahashi WY. Contrast sensitivity evaluation in high risk proliferative diabetic retinopathy treated with panretinal photocoagulation associated or not with intravitreal bevacizumab injections: a randomised clinical trial [Internet]. British Journal of Ophthalmology. 2013 ; 97( 7): 885-889.[citado 2026 mar. 12 ] Available from: https://doi.org/10.1136/bjophthalmol-2012-302675 -
Vancouver
Preti RC, Ramirez LMV, Monteiro MLR, Carra MK, Pelayes DE, Takahashi WY. Contrast sensitivity evaluation in high risk proliferative diabetic retinopathy treated with panretinal photocoagulation associated or not with intravitreal bevacizumab injections: a randomised clinical trial [Internet]. British Journal of Ophthalmology. 2013 ; 97( 7): 885-889.[citado 2026 mar. 12 ] Available from: https://doi.org/10.1136/bjophthalmol-2012-302675 - Optical coherence tomography analysis of outer retinal tubulations sequential evolution and pathophysiological insights
- Novel outer retinal optical coherence tomography hyperreflective abnormality associated with sub–internal limiting membrane hemorrhage
- Idiopathic polypoidal choroidal vasculopathy masquerading as choroidal tumors: one year follow-up of a peripheral lesion
- Structural and Functional Assessment of Macula in Patients with High-Risk Proliferative Diabetic Retinopathy Submitted to Panretinal Photocoagulation and Associated Intravitreal Bevacizumab Injections: A Comparative, Randomised, Controlled Trial
- Socioeconomic Barriers to Rhegmatogenous Detachment Surgery in Brazil
- Bilateral choroidal neovascularization response to unilateral intravitreal Ranibizumab injection in a patient with angioid streaks
- Use of intravitreal bevacizumab or triamcinolone acetonide as a preoperative adjunct to vitrectomy for vitreous haemorrhage in diabetics
- Autoimmune retinopathy: a review
- Short-term effects of intravitreal bevacizumab in contrast sensitivity of patients with diabetic macular edema and optimizing glycemic control
- Recurrent myopic foveoschisis: Resolution after internal limiting membrane removal
Informações sobre a disponibilidade de versões do artigo em acesso aberto coletadas automaticamente via oaDOI API (Unpaywall).
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
